FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 318:1414-1422 June 2, 1988 Number 22 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We evaluated the ability of human recombinant granulocyte colony-stimulating factor (rhG-CSF) to prevent chemotherapy-induced neutropenia or to accelerate recovery from this complication and thus allow patients to receive full doses of antineoplastic agents on time, according to protocol design. Twenty-seven patients with transitional-cell carcinoma of the urothelium who were undergoing treatment with methotrexate, doxorubicin, vinblastine, and cisplatin were given rhG-CSF (up to 60 micrograms per kilogram of body weight per day) before their first cycle of combination chemotherapy, during the first cycle, or at both points. Treatment with rhG-CSF before chemotherapy resulted in a dose-dependent increase in the absolute neutrophil count. Treatment with rhG-CSF after chemotherapy significantly reduced the number of days (91 percent) per patient on which the absolute neutrophil count was 1000 per microliter or less (P = 0.0039), reduced the number of days (1 vs. 35) on which antibiotics were used to treat fever and neutropenia, and significantly increased the percentage (100 vs. 29 percent) of patients qualified to receive planned chemotherapy on day 14 of the treatment cycle (P = 0.0015). In addition, the incidence of mucositis was significantly decreased (11 vs. 44 percent, P = 0.041), as was its severity. These findings demonstrate that rhG-CSF is a potent stimulus of normal neutrophil proliferation and maturation. In addition, its administration can reduce both the hematopoietic and oral toxicity of chemotherapy.

Source Information

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

This article has been cited by other articles:

• Milowsky, M. I., Nanus, D. M., Maluf, F. C., Mironov, S., Shi, W., Iasonos, A., Riches, J., Regazzi, A., Bajorin, D. F. (2009). Final Results of Sequential Doxorubicin Plus Gemcitabine and Ifosfamide, Paclitaxel, and Cisplatin Chemotherapy in Patients With Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium. JCO 27: 4062-4067 [Abstract] [Full Text]  
• Ip, E. J., Lee-Ma, A., Troxell, L. S., Chan, J. (2008). Low-dose filgrastim in patients with breast cancer treated with docetaxel, doxorubicin, and cyclophosphamide. Am J Health Syst Pharm 65: 1552-1555 [Abstract] [Full Text]  
• Ziepert, M., Schmits, R., Trumper, L., Pfreundschuh, M., Loeffler, M., On behalf of the German High-Grade Non-Hodgkin's L, (2008). Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin's lymphoma. Ann Oncol 19: 752-762 [Abstract] [Full Text]  
• Kuderer, N. M., Dale, D. C., Crawford, J., Lyman, G. H. (2007). Impact of Primary Prophylaxis With Granulocyte Colony-Stimulating Factor on Febrile Neutropenia and Mortality in Adult Cancer Patients Receiving Chemotherapy: A Systematic Review. JCO 25: 3158-3167 [Abstract] [Full Text]  
• Tokita, K., Uchida, Y., Yamamoto, T. (2006). Roles of leukocytosis and cysteinyl leukotriene in polymorphonuclear leukocyte-dependent plasma extravasation. J. Leukoc. Biol. 80: 1308-1319 [Abstract] [Full Text]  
• Martin, M., Lluch, A., Segui, M. A., Ruiz, A., Ramos, M., Adrover, E., Rodriguez-Lescure, A., Grosse, R., Calvo, L., Fernandez-Chacon, C., Roset, M., Anton, A., Isla, D., del Prado, P. M., Iglesias, L., Zaluski, J., Arcusa, A., Lopez-Vega, J. M., Munoz, M., Mel, J. R. (2006). Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen. Ann Oncol 17: 1205-1212 [Abstract] [Full Text]  
• Bamias, A., Tiliakos, I., Karali, M.-D., Dimopoulos, M. A. (2006). Systemic chemotherapy in inoperable or metastatic bladder cancer. Ann Oncol 17: 553-561 [Abstract] [Full Text]  
• Weycker, D., Hackett, J., Edelsberg, J. S, Oster, G., Glass, A. G (2006). Are Shorter Courses of Filgrastim Prophylaxis Associated with Increased Risk of Hospitalization?. The Annals of Pharmacotherapy 40: 402-407 [Abstract] [Full Text]  
• Du, X. L., Lairson, D. R., Begley, C. E., Fang, S. (2005). Temporal and Geographic Variation in the Use of Hematopoietic Growth Factors in Older Women Receiving Breast Cancer Chemotherapy: Findings From a Large Population-Based Cohort. JCO 23: 8620-8628 [Abstract] [Full Text]  
• Kurzrock, R. (2005). Thrombopoietic Factors in Chronic Bone Marrow Failure States: The Platelet Problem Revisited. Clin. Cancer Res. 11: 1361-1367 [Abstract] [Full Text]  
• Bamias, A., Aravantinos, G., Deliveliotis, C., Bafaloukos, D., Kalofonos, C., Xiros, N., Zervas, A., Mitropoulos, D., Samantas, E., Pectasides, D., Papakostas, P., Gika, D., Kourousis, C., Koutras, A., Papadimitriou, C., Bamias, C., Kosmidis, P., Dimopoulos, M.A. (2004). Docetaxel and Cisplatin With Granulocyte Colony-Stimulating Factor (G-CSF) Versus MVAC With G-CSF in Advanced Urothelial Carcinoma: A Multicenter, Randomized, Phase III Study From the Hellenic Cooperative Oncology Group. JCO 22: 220-228 [Abstract] [Full Text]  
• Adachi, K., Suzuki, M., Sugimoto, T., Yorozu, K., Takai, H., Uetsuka, K., Nakayama, H., Doi, K. (2003). Effects of Granulocyte Colony-Stimulating Factor (G-CSF) on Bleomycin-Induced Lung Injury of Varying Severity. Toxicol Pathol 31: 665-673 [Abstract]  
• Dazzi, C., Cariello, A., Giovanis, P., Monti, M., Vertogen, B., Leoni, M., Tienghi, A., Turci, D., Rosti, G., Nanni, O., Rondoni, C., Marangolo, M. (2003). Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, randomized, placebo-controlled study. Ann Oncol 14: 559-563 [Abstract] [Full Text]  
• Green, M. D., Koelbl, H., Baselga, J., Galid, A., Guillem, V., Gascon, P., Siena, S., Lalisang, R. I., Samonigg, H., Clemens, M. R., Zani, V., Liang, B. C., Renwick, J., Piccart, M. J. (2003). A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy. Ann Oncol 14: 29-35 [Abstract] [Full Text]  
• Holmes, F.A., O'Shaughnessy, J.A., Vukelja, S., Jones, S.E., Shogan, J., Savin, M., Glaspy, J., Moore, M., Meza, L., Wiznitzer, I., Neumann, T.A., Hill, L.R., Liang, B.C. (2002). Blinded, Randomized, Multicenter Study to Evaluate Single Administration Pegfilgrastim Once per Cycle Versus Daily Filgrastim as an Adjunct to Chemotherapy in Patients With High-Risk Stage II or Stage III/IV Breast Cancer. JCO 20: 727-731 [Abstract] [Full Text]  
• Patte, C., Laplanche, A., Bertozzi, A. I., Baruchel, A., Frappaz, D., Schmitt, C., Mechinaud, F., Nelken, B., Boutard, P., Michon, J. (2002). Granulocyte Colony-Stimulating Factor in Induction Treatment of Children With Non-Hodgkin's Lymphoma: A Randomized Study of the French Society of Pediatric Oncology. JCO 20: 441-448 [Abstract] [Full Text]  
• Kostler, W. J., Hejna, M., Wenzel, C., Zielinski, C. C. (2001). Oral Mucositis Complicating Chemotherapy and/or Radiotherapy: Options for Prevention and Treatment. CA Cancer J Clin 51: 290-315 [Abstract] [Full Text]  
• Sternberg, C. N., de Mulder, P. H.M., Schornagel, J. H., Theodore, C., Fossa, S. D., van Oosterom, A. T., Witjes, F., Spina, M., van Groeningen, C. J., de Balincourt, C., Collette, L. (2001). Randomized Phase III Trial of High-Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924. JCO 19: 2638-2646 [Abstract] [Full Text]  
• Ozer, H., Armitage, J. O., Bennett, C. L., Crawford, J., Demetri, G. D., Pizzo, P. A., Schiffer, C. A., Smith, T. J., Somlo, G., Wade, J. C., Wade, J. L. III, Winn, R. J., Wozniak, A. J., Somerfield, M. R., for the American Society of Clinical Oncology Gro, (2000). 2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines. JCO 18: 3558-3585 [Full Text]  
• Rodgers, K., Xiong, S., Espinoza, T., Roda, N., Maldonado, S., diZerega, G. S. (2000). Angiotensin II Increases Host Resistance to Peritonitis. CVI 7: 635-640 [Abstract] [Full Text]  
• Koukourakis, M. I., Flordellis, C. S., Giatromanolaki, A., Koukouraki, S., Kapsoritakis, A., Potamianos, S., Retalis, G., Sivridis, E., Salsaa, B., Harris, A. L., Maragoudakis, M. I. (1999). Oral Administration of Recombinant Human Granulocyte Macrophage Colony-stimulating Factor in the Management of Radiotherapy-induced Esophagitis. Clin. Cancer Res. 5: 3970-3976 [Abstract] [Full Text]  
• Ashitani, J.-i., Mukae, H., Taniguchi, H., Ihi, T., Kadota, J.-i., Kohno, S., Matsukura, S. (1999). Granulocyte-colony stimulating factor levels in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis. Thorax 54: 1015-1020 [Abstract] [Full Text]  
• Bajorin, D. F., Dodd, P. M., Mazumdar, M., Fazzari, M., McCaffrey, J. A., Scher, H. I., Herr, H., Higgins, G., Boyle, M. G. (1999). Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy. JCO 17: 3173-3181 [Abstract] [Full Text]  
• Shapiro, J. D., Harold, N., Takimoto, C., Hamilton, J. M., Vaughn, D., Chen, A., Steinberg, S. M., Liewehr, D., Allegra, C., Monahan, B., Lash, A., Grollman, F., Flemming, D., Behan, K., Johnston, P. G., Haller, D., Quinn, M., Morrison, G., Grem, J. L. (1999). A Pilot Study of Interferon {{alpha}}-2a, Fluorouracil, and Leucovorin Given with Granulocyte-Macrophage Colony Stimulating Factor in Advanced Gastrointestinal Adenocarcinoma. Clin. Cancer Res. 5: 2399-2408 [Abstract] [Full Text]  
• Dodd, P. M., McCaffrey, J. A., Herr, H., Mazumdar, M., Bacik, J., Higgins, G., Boyle, M. G., Scher, H. I., Bajorin, D. F. (1999). Outcome of Postchemotherapy Surgery After Treatment With Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Patients With Unresectable or Metastatic Transitional Cell Carcinoma. JCO 17: 2546-2546 [Abstract] [Full Text]  
• Klein, P., Muggia, F. M. (1999). Cytoprotection: Shelter from the Storm. The Oncologist 4: 112-121 [Full Text]  
• Kaplan, A., Kaplan, S., Marcoe, K. F., Sauvage, L. R., Hammond, W. P. (1998). The Effect of Hematopoietic Growth Factors on Platelet Aggregability. CLIN APPL THROMB HEMOST 4: 238-242 [Abstract]  
• Godwin, J. E., Kopecky, K. J., Head, D. R., Willman, C. L., Leith, C. P., Hynes, H. E., Balcerzak, S. P., Appelbaum, F. R. (1998). A Double-Blind Placebo-Controlled Trial of Granulocyte Colony-Stimulating Factor in Elderly Patients With Previously Untreated Acute Myeloid Leukemia: A Southwest Oncology Group Study (9031). Blood 91: 3607-3615 [Abstract] [Full Text]  
• Heil, G., Hoelzer, D., Sanz, M. A., Lechner, K., Liu Yin, J. A., Papa, G., Noens, L., Szer, J., Ganser, A., O'Brien, C., Matcham, J., Barge, A. (1997). A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia. Blood 90: 4710-4718 [Abstract] [Full Text]  
• Talcott, J. A. (1997). Outpatient Management of Febrile Neutropenia: Should We Change the Standard of Care?. The Oncologist 2: 365-373 [Abstract] [Full Text]  
• Neelis, K. J., Hartong, S. C.C., Egeland, T., Thomas, G. R., Eaton, D. L., Wagemaker, G. (1997). The Efficacy of Single-Dose Administration of Thrombopoietin With Coadministration of Either Granulocyte/Macrophage or Granulocyte Colony-Stimulating Factor in Myelosuppressed Rhesus Monkeys. Blood 90: 2565-2573 [Abstract] [Full Text]  
• Anderlini, P., Korbling, M., Dale, D., Gratwohl, A., Schmitz, N., Stroncek, D., Howe, C., Leitman, S., Horowitz, M., Gluckman, E., Rowley, S., Przepiorka, D., Champlin, R. (1997). Allogeneic Blood Stem Cell Transplantation: Considerations for Donors. Blood 90: 903-908 [Abstract] [Full Text]  
• Geissler, K., Koller, E., Hubmann, E., Niederwieser, D., Hinterberger, W., Geissler, D., Kyrle, P., Knobl, P., Pabinger, I., Thalhammer, R., Schwarzinger, I., Mannhalter, C., Jaeger, U., Heinz, R., Linkesch, W., Lechner, K. (1997). Granulocyte Colony-Stimulating Factor as an Adjunct to Induction Chemotherapy for Adult Acute Lymphoblastic Leukemia --- A Randomized Phase-III Study. Blood 90: 590-596 [Abstract] [Full Text]  
• Moore, R. D., Keruly, J. C., Chaisson, R. E. (1995). Neutropenia and Bacterial Infection in Acquired Immunodeficiency Syndrome. Arch Intern Med 155: 1965-1970 [Abstract]  
• Kaczmarski, R. S., Mufti, G. J. (1993). Low-Dose Filgrastim Therapy for Chronic Neutropenia. NEJM 329: 1280-1281 [Full Text]  
• Pizzo, P. A. (1993). Management of Fever in Patients with Cancer and Treatment-Induced Neutropenia. NEJM 328: 1323-1332 [Full Text]  
• Gulati, S. C., Bennett, C. L. (1992). Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) as Adjunct Therapy in Relapsed Hodgkin Disease. ANN INTERN MED 116: 177-182 [Abstract]  
• Lindley, C. M., Gordon, T. R. (1991). Application of Biotechnology Products in Oncology. Journal of Pharmacy Practice 4: 117-130  
• Louie, S. G., Jaresko, G. S. (1991). Biological Agents in Infectious Diseases. Journal of Pharmacy Practice 4: 326-341 [Abstract]  
• Cioffi, W. G. Jr, Burleson, D. G., Jordan, B. S., Becker, W. K., McManus, W. F., Mason, A. D. Jr, Pruitt, B. A. Jr (1991). Effects of Granulocyte-Macrophage Colony-Stimulating Factor in Burn Patients. Arch Surg 126: 74-79 [Abstract]  
• Negrin, R. S., Haeuber, D. H., Nagler, A., Olds, L. C., Donlon, T., Souza, L. M., Greenberg, P. L. (1989). Treatment of Myelodysplastic Syndromes with Recombinant Human Granulocyte Colony-Stimulating Factor: A Phase I-II Trial. ANN INTERN MED 110: 976-984 [Abstract]  
• Reidenberg, M. M. (1989). Clinical Pharmacology. JAMA 261: 2831-2832 [Abstract]  
• Lieschke, G. J., Maher, D., Cebon, J., O'Connor, M., Green, M., Sheridan, W., Boyd, A., Rallings, M., Bonnem, E., Metcalf, D., Burgess, A. W., McGrath, K., Fox, R. M., Morstyn, G. (1989). Effects of Bacterially Synthesized Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Patients with Advanced Malignancy. ANN INTERN MED 110: 357-364 [Abstract]  
• Glaspy, J. A., Baldwin, G. C., Robertson, P. A., Souza, L., Vincent, M., Ambersley, J., Golde, D. W. (1988). Therapy for Neutropenia in Hairy Cell Leukemia with Recombinant Human Granulocyte Colony-Stimulating Factor. ANN INTERN MED 109: 789-795 [Abstract]  
• (1988). COLONY-STIMULATING FACTORS SHOW PROMISE. JWatch General 1988: 5-5 [Full Text]